Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
about
Metabolic functions of FABPs--mechanisms and therapeutic implicationsAdipokines as a novel link between obesity and atherosclerosisThe role of fatty acid binding proteins in metabolic syndrome and atherosclerosisCigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infectionSerum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal diseaseObesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.FABP4 plasma levels are increased in familial combined hyperlipidemia.Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity.Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemiaA genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular diseaseRelation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice.Nutrition and metabolic correlates of obesity and inflammation: clinical considerations.Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults.Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem CellsMechanisms of triglyceride accumulation in activated macrophagesPlasma levels of FABP4, but not FABP3, are associated with increased risk of diabetesElevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study.Drug discovery in the metabolic syndrome: context and some recent developments.Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injury.Serum adipocyte fatty acid-binding protein in the critically illFatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study.Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice.Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adultsPlasma Fatty Acid binding protein 4 and risk of sudden cardiac death in older adults.Early programming of adipose tissue function: a large-animal perspective.A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes.Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.Molecular biology of atherosclerosis.Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability.Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation.
P2860
Q26799705-889B2D62-B252-4008-9133-74AFC6A53ECDQ26852200-121D2E7C-C029-44EB-A843-6B2BE9FD052CQ28271189-D4D34186-5712-48B5-A3D7-C8380610E2F6Q28393450-0A143EE9-CB4E-4149-B7B5-DCD0A6DF3344Q28477907-EC23D513-E075-4DB8-90DD-08114A3CE298Q33628222-F4BB2684-92D7-42A7-9F1A-DA8DB37DF204Q33649348-DBBED820-A59B-4858-8975-A3A0C85D6BCDQ33784529-2CBFF67B-9564-4671-AC2E-D99C06DA2B7CQ34064920-FF725D6C-7CCE-468C-8C43-9AE57F9568B8Q34455370-D877D9F2-981A-4411-9596-B93AA6CC00F2Q34478852-0D41578B-1F62-4DAC-A142-43D9B9F0FB6CQ34565501-50D7AD05-0644-4EF2-B671-EFEBC3CB6BF8Q35025881-2E47720E-9B18-40D3-90FF-C8F2669DF6E7Q35042217-0FEE22E5-DB8D-41D4-8CFE-505EFD30ABA1Q35101512-484952B4-4DD7-48C6-8AE2-46379DBD0CBFQ35178548-7D7BA7DC-7C17-4058-8ADC-BFF7B0462F5DQ35540750-6873DE07-1839-4BC8-9C81-FD10C0209BAAQ35859743-EFA4EDCC-B395-4982-81DD-2F3F0B2E98D3Q36109097-E2B9A0DF-3312-4568-9184-976645D4947AQ36218431-00CC976E-7FA1-4A1B-BC46-D66A0E6DBE0DQ36232209-0D21723A-F94A-42B6-AEF2-7144D0128D73Q36471397-C3C281CD-9320-462C-B63B-23AA14C7A67EQ36701727-9B32EDCE-DF7B-4041-8059-4774CCD5182DQ36822448-8CBF9B5F-8014-4A99-8628-8D11F0F0ACDEQ36901475-CB41EC1A-744D-4982-A87B-E97447AA9B80Q36902526-45ADD5B4-A122-46C6-A0BF-C0EF721F259CQ37000007-C0426D39-7DF9-4BE8-8357-EA0C4CA48148Q37022969-3894E933-5760-4106-B88D-8246EA5BEC2AQ37294001-75A37807-7C38-420C-A92A-B68053DB150EQ37444313-B511FB92-4580-4AD8-8F70-2176C153ABD5Q37465830-C2557E7A-DDE0-448A-8B3B-1F6D7FCC2974Q37589776-DC20464B-035F-4A84-9659-23EC73B110A0Q37622432-0949C22F-D321-46BC-AE01-54E24022B601Q37691786-37ADE85D-C362-40B5-B515-9E7523C4C443Q37972596-F5E9CAF6-B1AC-40A8-B5CD-18AD7EB836A5Q38050907-DEFB1860-D06A-42E4-9BE4-FFB68B30E10EQ38071250-4AEF2438-FF3C-4E81-A1B5-B88714743830Q38125279-69AD69CE-CBDA-411A-BB52-5176438C3004Q38263804-5F2DDCD7-FDBC-40DE-B8F2-37C7174455B9Q38715896-A2155CA4-3B89-4001-A4FD-4C42A8ECF3AE
P2860
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@ast
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@en
type
label
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@ast
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@en
prefLabel
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@ast
Combined adipocyte-macrophage ...... olipoprotein E-deficient mice.
@en
P2093
P2860
P921
P1433
P1476
Combined adipocyte-macrophage ...... polipoprotein E-deficient mice
@en
P2093
Gökhan S Hotamisligil
Jeffrey B Boord
Kazuhisa Maeda
MacRae F Linton
Sergio Fazio
Vladimir R Babaev
P2860
P304
P356
10.1161/01.CIR.0000141735.13202.B6
P407
P577
2004-09-07T00:00:00Z